LUTADENOVEC AUTOGENE
UNII AJ42U9BVW4

Substance Identification & Data

This profile provides standardized clinical and technical data for Lutadenovec Autogene, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AJ42U9BVW4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2805319-15-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AJ42U9BVW4

CAS Registry Number

2805319-15-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUTADENOVEC AUTOGENE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156925

National Cancer Institute reference terminology for clinical and research data.

INN ID

13100

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-169

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lutadenovec Autogene. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUTADENOVEC AUTOGENE

Common Names & Synonyms

DNA (CHIMPANZEE ADENOVIRUS 68-DERIVED CONSTRUCT GRT-C901 VIRAL PROTEIN GENE E1 DELETION PLUS VIRAL PROTEIN GENE E3 DELETION PLUS VIRAL PROTEIN GENE E4 DELETION-CONTAINING PLUS CYTOMEGALOVIRUS PROMOTER PLUS TRANSCRIPTION FACTOR TETR (TETRACYLINE REPRESSOR)-RESPONSE ELEMENT CMT PLUS TUMOR-SPECIFIC NEOANTIGEN PROTOTYPE CASSETTE-EXPRESSING)

GRT C901 [WHO-DD]

GRT-C901

LUTADENOVEC AUTOGENE [INN]

LUTADENOVEC AUTOGENE [USAN]